Title: |
Experts consensus on the clinical application of liver contrast-enhanced US with Sonazoid in China |
Edition: |
Original |
Classification: |
Experts consensus |
Field: |
Comprehensive guideline |
Countries and regions: |
China |
Guidelines users: |
Sonographers and clinicians involved in the clinical care of liver diseases from medical institutions at all levels |
Evidence classification method: |
Grading of Recommendations Assessment, Development and Evaluation (GRADE) |
Development unit: |
Chinese Society of Ultrasound in Medicine |
Registration time: |
2024-04-02 |
Registration number: |
PREPARE-2024CN484 |
Purpose of the guideline: |
Sonazoid is a Kupffer-cell specific contrast agent. Contrast-enhanced US with Sonazoid plays a very important role in the screening, diagnosis, intraoperative and interventional procedures, and efficacy assessment of liver diseases. We aimed to standardize the use of contrast-enhanced US with Sonazoid in the management of liver disease in the experts consensus. |